TC
UTHR icon

TwinBeech Capital’s United Therapeutics UTHR Stock Holding History

TwinBeech Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,036
Closed -$1.69M – 860
2025
Q3 		$1.69M Sell
4,036
-19,246
-83% -$6.47M 0.07% 248
2025
Q2 		$6.69M Buy
+23,282
New +$6.96M 0.15% 170
2024
Q1 		– Sell
-70,267
Closed -$15.5M – 868
2023
Q4 		$15.5M Buy
70,267
+67,518
+2,456% +$15.6M 0.25% 116
2023
Q3 		$621K Buy
+2,749
New +$633K 0.01% 530
2021
Q4 		– Sell
-21,466
Closed -$3.96M – 827
2021
Q3 		$3.96M Buy
+21,466
New +$4.23M 0.28% 108
2020
Q1 		– Sell
-4,195
Closed -$369K – 488
2019
Q4 		$369K Buy
+4,195
New +$369K 0.11% 261

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return